Idenix Pharmaceuticals to Present at Deutsche Bank's 2008 Biotech Boston Confab

Tuesday, November 11, 2008 General News J E 4
CAMBRIDGE, Mass., Nov. 7 Idenix Pharmaceuticals,Inc. (Nasdaq: IDIX) announced today that management will present at DeutscheBank's 2008 Biotech Boston Confab on Tuesday, November 11th at 9:40 a.m. ET.

The live and archived webcast of the presentation can be accessed under"Calendar of Events" in the Idenix Investor Center at log in approximately 5-10 minutes before the event to ensure a timelyconnection. The archived replay will be available on the Idenix website fortwo weeks following the conference.

About Idenix

Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts,is a biopharmaceutical company engaged in the discovery and development ofdrugs for the treatment of human viral and other infectious diseases. Idenix'scurrent focus is on the treatment of infections caused by the hepatitis Cvirus and HIV. For further information about Idenix, please refer to

Idenix Pharmaceuticals' Contacts:

Media: Teri Dahlman (617) 995-9905

Investors: Amy Sullivan (617) 995-9838

SOURCE Idenix Pharmaceuticals, Inc.


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
FDA Approves Boston Scientific's Apex(TM) PTCA Dil...
CVS Caremark Fertility Managed Plan Helps Couples ...